Literature DB >> 23435612

Type 2 diabetes and fractures: more information is needed.

Mishaela R Rubin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23435612     DOI： 10.1007/s12020-013-9901-6

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  12 in total

1.  Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes.

Authors:  Ann V Schwartz; Eric Vittinghoff; Douglas C Bauer; Teresa A Hillier; Elsa S Strotmeyer; Kristine E Ensrud; Meghan G Donaldson; Jane A Cauley; Tamara B Harris; Annemarie Koster; Catherine R Womack; Lisa Palermo; Dennis M Black
Journal:  JAMA       Date:  2011-06-01       Impact factor: 56.272

2.  Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study.

Authors:  Didier Hans; Andrew L Goertzen; Marc-Antoine Krieg; William D Leslie
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

3.  Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study.

Authors:  Denise E Bonds; Joseph C Larson; Ann V Schwartz; Elsa S Strotmeyer; John Robbins; Beatriz L Rodriguez; Karen C Johnson; Karen L Margolis
Journal:  J Clin Endocrinol Metab       Date:  2006-06-27       Impact factor: 5.958

4.  FRAX underestimates fracture risk in patients with diabetes.

Authors:  Lora M Giangregorio; William D Leslie; Lisa M Lix; Helena Johansson; Anders Oden; Eugene McCloskey; John A Kanis
Journal:  J Bone Miner Res       Date:  2012-02       Impact factor: 6.741

5.  Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus.

Authors:  Antonia García-Martín; Pedro Rozas-Moreno; Rebeca Reyes-García; Sonia Morales-Santana; Beatriz García-Fontana; José A García-Salcedo; Manuel Muñoz-Torres
Journal:  J Clin Endocrinol Metab       Date:  2011-10-26       Impact factor: 5.958

Review 6.  Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture.

Authors:  Mohsen Janghorbani; Rob M Van Dam; Walter C Willett; Frank B Hu
Journal:  Am J Epidemiol       Date:  2007-06-16       Impact factor: 4.897

7.  Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate.

Authors:  S Y Tang; M R Allen; R Phipps; D B Burr; D Vashishth
Journal:  Osteoporos Int       Date:  2008-10-11       Impact factor: 4.507

8.  Vertebral fracture assessment using a semiquantitative technique.

Authors:  H K Genant; C Y Wu; C van Kuijk; M C Nevitt
Journal:  J Bone Miner Res       Date:  1993-09       Impact factor: 6.741

9.  Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus.

Authors:  Christine Hamann; Martina Rauner; Yvonne Höhna; Ricardo Bernhardt; Jan Mettelsiefen; Claudia Goettsch; Klaus-Peter Günther; Marina Stolina; Chun-Ya Han; Franklin J Asuncion; Michael S Ominsky; Lorenz C Hofbauer
Journal:  J Bone Miner Res       Date:  2013-03       Impact factor: 6.741

10.  Vertebral fractures in males with type 2 diabetes treated with rosiglitazone.

Authors:  Tatiana Mancini; Gherardo Mazziotti; Mauro Doga; Rita Carpinteri; Niksa Simetovic; Pier Paolo Vescovi; Andrea Giustina
Journal:  Bone       Date:  2009-06-13       Impact factor: 4.398
View more
  2 in total

Review 1.  Utility of the trabecular bone score (TBS) in secondary osteoporosis.

Authors:  Fabio M Ulivieri; Barbara C Silva; Francesco Sardanelli; Didier Hans; John P Bilezikian; Renata Caudarella
Journal:  Endocrine       Date:  2014-05-23       Impact factor: 3.633

2.  Correlation of serum testosterone with insulin resistance in elderly male type 2 diabetes mellitus patients with osteoporosis.

Authors:  Jin-Wei Xia; Shi-Jin Tan; Xing-Liang Zhang; Tao Jun; Xiao-Kang Sun; Wang Ling
Journal:  J Diabetes Investig       Date:  2015-06-15       Impact factor: 4.232
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.